+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Bioreactors Market (2022-2027) by Product Type, Cell, Molecule, Usage, End-User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 190 Pages
  • August 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5669264
UP TO OFF until Dec 31st 2023

The rise in research and development activities to cater to effective novel therapies in cancer treatment is poised to impel the bioreactors industry's demand

The Global Bioreactors Market is estimated to be USD 1.66 Bn in 2022 and is expected to reach USD 2.68 Bn by 2027, growing at a CAGR of 10.06%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Bioreactors Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing risks.

Market Segmentations

The Global Bioreactors Market is segmented based on Product Type, Cell, Molecule, Usage, End-User, and Geography.
  • By Product Type, the market is classified into Single-use and Reusable.
  • By Cell, the market is classified into Mammalian Cells, Bacterial Cells, Yeast Cells, and Others.
  • By Molecule, the market is classified into Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, and Others.
  • By Usage, the market is classified into Developmental, Pre-Clinical & Clinical, and Commercial Production.
  • By End-User, the market is classified into R&D Organizations, Biopharmaceutical Manufacturers, and Contract Manufacturing Organizations (CMO).
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are 3D Biotek LLC, Praj Hipurity Systems Ltd., Sartorius AG, Solaris Biotechnology S.r.l, Solida Biotech GmBH, Thermo Fisher Scientific Inc., ZETA Holding GmbH, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Bioreactors Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Bioreactors Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Bioreactors Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Bioreactors Market

What is the estimated value of the Global Bioreactors Market?

The Global Bioreactors Market was estimated to be valued at $1.66 Billion in 2022.

What is the growth rate of the Global Bioreactors Market?

The growth rate of the Global Bioreactors Market is 10.0%, with an estimated value of $2.68 Billion by 2027.

What is the forecasted size of the Global Bioreactors Market?

The Global Bioreactors Market is estimated to be worth $2.68 Billion by 2027.

Who are the key companies in the Global Bioreactors Market?

Key companies in the Global Bioreactors Market include 3D Biotek LLC, Applikon Biotechnology BV, BBI, Biotech GmbH, Bioengineering AG, Broadley, James Corp., Cell Culture Company, Cytiva and Eppendorf AG.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rapid Growth of the Biopharmaceuticals and Biologics Industry
4.1.2 Technology Advancements in Bioreactors
4.1.3 Adoption of Single-Use Bioreactors (Subs) and Hybrid Bioreactors
4.1.4 Increasing Demand for Personalized Medicine
4.2 Restraints
4.2.1 Low Capacity of Single-Use Bioreactor or Disposable Bioreactor
4.2.2 Concerns Regarding Extrables and Leachables
4.3 Opportunities
4.3.1 High Market Potential in Emerging Economies
4.3.2 Rising Demand for Personalized Medicine
4.4 Challenges
4.4.1 Stringent Regulatory Framework
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
5.5 PESTLE Analysis
6 Global Bioreactors Market, By Product Type
6.1 Introduction
6.2 Single-use
6.3 Reusable
7 Global Bioreactors Market, By Cell
7.1 Introduction
7.2 Mammalian Cells
7.3 Bacterial Cells
7.4 Yeast Cells
7.5 Others
8 Global Bioreactors Market, By Molecule
8.1 Introduction
8.2 Monoclonal Antibodies
8.3 Vaccines
8.4 Recombinant Proteins
8.5 Stem Cells
8.6 Gene Therapy
8.7 Others
9 Global Bioreactors Market, By Usage
9.1 Introduction
9.2 Developmental, Pre-Clinical & Clinical
9.3 Commercial Production
10 Global Bioreactors Market, By End-User
10.1 Introduction
10.2 R&D Organizations
10.3 Biopharmaceutical Manufacturers
10.4 Contract Manufacturing Organizations (CMO)
11 Americas’ Bioreactors Market
11.1 Introduction
11.2 Argentina
11.3 Brazil
11.4 Canada
11.5 Chile
11.6 Colombia
11.7 Mexico
11.8 Peru
11.9 United States
11.10 Rest of Americas
12 Europe’s Bioreactors Market
12.1 Introduction
12.2 Austria
12.3 Belgium
12.4 Denmark
12.5 Finland
12.6 France
12.7 Germany
12.8 Italy
12.9 Netherlands
12.10 Norway
12.11 Poland
12.12 Russia
12.13 Spain
12.14 Sweden
12.15 Switzerland
12.16 United Kingdom
12.17 Rest of Europe
13 Middle East and Africa’s Bioreactors Market
13.1 Introduction
13.2 Egypt
13.3 Israel
13.4 Qatar
13.5 Saudi Arabia
13.6 South Africa
13.7 United Arab Emirates
13.8 Rest of MEA
14 APAC’s Bioreactors Market
14.1 Introduction
14.2 Australia
14.3 Bangladesh
14.4 China
14.5 India
14.6 Indonesia
14.7 Japan
14.8 Malaysia
14.9 Philippines
14.10 Singapore
14.11 South Korea
14.12 Sri Lanka
14.13 Thailand
14.14 Taiwan
14.15 Rest of Asia-Pacific
15 Competitive Landscape
15.1 IGR Competitive Quadrant
15.2 Market Share Analysis
15.3 Strategic Initiatives
15.3.1 M&A and Investments
15.3.2 Partnerships and Collaborations
15.3.3 Product Developments and Improvements
16 Company Profiles
16.1 3D Biotek LLC
16.2 Applikon Biotechnology BV
16.3 BBI-Biotech GmbH
16.4 Bioengineering AG
16.5 Broadley-James Corp.
16.6 Cell Culture Company
16.7 Cytiva
16.8 Eppendorf AG
16.9 GEA Group AG
16.10 Infors AG
16.11 Merck KGaA
16.12 Pall Corp.
16.13 Pierre Guérin SAS
16.14 Praj Hipurity Systems Ltd.
16.15 Sartorius AG
16.16 Solaris Biotechnology S.r.l
16.17 Solida Biotech GmBH
16.18 Thermo Fisher Scientific Inc.
16.19 ZETA Holding GmbH
17 Appendix
17.1 Questionnaire

Companies Mentioned

  • 3D Biotek LLC
  • Applikon Biotechnology BV
  • BBI-Biotech GmbH
  • Bioengineering AG
  • Broadley-James Corp.
  • Cell Culture Company
  • Cytiva
  • Eppendorf AG
  • GEA Group AG
  • Infors AG
  • Merck KGaA
  • Pall Corp.
  • Pierre Guérin SAS
  • Praj Hipurity Systems Ltd.
  • Sartorius AG
  • Solaris Biotechnology S.r.l
  • Solida Biotech GmBH
  • Thermo Fisher Scientific Inc.
  • ZETA Holding GmbH